Lv61
2210 积分 2021-12-28 加入
CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma
2天前
已完结
Diagnostics and Therapeutic Potential of miR-205 and miR-34a in Ovarian Cancer Management: A miRNA-Target-Based Analysis
11天前
已完结
Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein–Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy
14天前
已完结
An update patent review of MDM2-p53 interaction inhibitors (2019–2023)
14天前
已完结
Proximity-enabled bioreactivity to generate covalent peptide inhibitors of p53–Mdm4
15天前
已完结
Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms
17天前
已完结
Leveraging Flavonoids as Potential Inhibitors of METTL3 in Combating Cancer: A Combined Structure‐Based Drug Design and DFT Approach
22天前
已完结
Virtual Screening and Molecular Docking: Discovering Novel METTL3 Inhibitors
22天前
已完结
Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond “Failure to rescue”
2个月前
已完结
Structure-Based Discovery of MDM2/4 Dual Inhibitors that Exert Antitumor Activities against MDM4-Overexpressing Cancer Cells
3个月前
已完结
皖公网安备34019202002308
